Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 4/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | APLNR | P35414 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7342949 | 0.98 | MAOA (0.39) | MAOAMAOBTDP1CA12CA14 | |
| Trifluoroacetic Acid SCHEMBL27557005 | 0.89 | F2 (0.36) | MAOAMAOBTDP1CA12CA14 | |
| Guanidine SCHEMBL18128882 | 0.84 | MAOA (0.39) | MAOAMAOBTDP1CA12CA14 | |
| SCHEMBL14661964 | 0.81 | CRBN (0.42) | MAOAMAOBTDP1CA12CA14 | |
| SCHEMBL604019 | 0.81 | TDP1 (0.39) | TDP1CA12CA14NFKB1NFKB2 | |
| SCHEMBL6951911 | 0.80 | DGAT1 (0.35) | MAOAMAOBDGAT1 | |
| SCHEMBL101218 | 0.80 | DGAT1 (0.46) | TDP1CA12CA14NFKB1NFKB2 | |
| SCHEMBL28910567 | 0.79 | MAOA (0.36) | MAOAMAOBTDP1CA12CA14 | |
| SCHEMBL10227847 | 0.79 | TDP1 (0.38) | TDP1CA12CA14NFKB1NFKB2 | |
| SCHEMBL8229349 | 0.78 | TAS2R38 (0.39) | MAOAMAOBTDP1CA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 451 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119015834-A | Carbon dioxide separation membrane and preparation method thereof | 国家能源投资集团有限责任公司 | 2024-11-26 | — | — | CN | claimed |
| CN-118994019-A | Process for the preparation of (R) -2- ((R) -2' -amino-4 ',5' -dihydro-1 ' H-imidazol-4 ' -yl) -6-methylhept-5-enoate derivatives | 临沂大学 | 2024-11-22 | — | — | CN | claimed |
| CN-116444528-A | Oxo-triazine piperazine heterocyclic compound and preparation method and application thereof | 中国人民解放军军事科学院军事医学研究院 | 2023-07-18 | — | — | CN | claimed |
| CN-115843205-B | Perovskite film layer preparation method and perovskite solar cell | 中国华能集团清洁能源技术研究院有限公司 | 2023-05-23 | — | — | CN | claimed |
| CN-116133442-A | Perovskite solar cell based on organic molecule modified lithium salt doped hole transport layer | 陕西师范大学 | 2023-05-16 | — | — | CN | claimed |
| CN-110869350-B | Alkynyl compounds, their preparation and their therapeutic use | 赛诺菲 | 2023-05-02 | — | — | CN | claimed |
| CN-115028554-B | Guanfacine hydrochloride and preparation method thereof | 海南慧谷药业有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-115843205-A | Preparation method of perovskite film layer and perovskite solar cell | 中国华能集团清洁能源技术研究院有限公司 | 2023-03-24 | — | — | CN | claimed |
| CN-110698413-B | Substituted pyrimidine derivative containing guanidyl, pharmaceutical composition thereof, and preparation method and application thereof | 中国海洋大学 | 2023-01-24 | — | — | CN | claimed |
| CN-115028554-A | Guanfacine hydrochloride and preparation method thereof | 广东科泰鼎润药业科技有限公司 | 2022-09-09 | — | — | CN | claimed |
| CN-112827368-A | Anti-pollution reverse osmosis membrane and preparation method thereof | 中化(宁波)润沃膜科技有限公司 | 2021-05-25 | — | — | CN | claimed |
| CN-112375055-A | Preparation method of eptifibatide key raw material L-high arginine | 宁夏蓝博思化学技术有限公司 | 2021-02-19 | — | — | CN | claimed |
| CN-112358423-A | Preparation and application of novel polypeptide guanidizing agent | 宁夏蓝博思化学技术有限公司 | 2021-02-12 | — | — | CN | claimed |
| CN-110698413-A | Substituted pyrimidine derivative containing guanidyl, pharmaceutical composition thereof, and preparation method and application thereof | 中国海洋大学 | 2020-01-17 | — | — | CN | claimed |
| CN-108869233-A | A kind of small-sized pressure stabilizing long axis Fire Fighting Pumps using novel coolant | 贝德科技有限公司 | 2018-11-23 | — | — | CN | claimed |
| US-20160296449-A1 | Semi-Permanent Hair Straightening Composition And Method | LUBRIZOL ADVANCED MATERIALS, INC. | 2016-10-13 | — | — | US | claimed |
| EP-3065831-A1 | SEMI-PERMANENT HAIR STRAIGHTENING COMPOSITION AND METHOD | Lubrizol Advanced Materials, Inc. (US) | 2016-09-14 | — | — | EP | claimed |
| CN-105916556-A | Semi-permanent hair straightening composition and method | 路博润先进材料公司 | 2016-08-31 | — | — | CN | claimed |
| WO-2015069823-A1 | SEMI-PERMANENT HAIR STRAIGHTENING COMPOSITION AND METHOD | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2015-05-14 | — | — | WO | claimed |
| CN-102753546-A | 5-membered heterocyclic derivatives and process for producing the same | ILDONG PHARM CO LTD | 2012-10-24 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160296449-A1 | Semi-Permanent Hair Straightening Composition And Method | KRT18, PRKDC, DNMT1 | MAOA 1027/4885MAOB 937/4885TDP1 1745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.